The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ladasky, J. J.
Right arrow Articles by Edidin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ladasky, J. J.
Right arrow Articles by Edidin, M.
The Journal of Immunology, 2006, 177: 6172-6181.
Copyright © 2006 by The American Association of Immunologists, Inc.

Bap31 Enhances the Endoplasmic Reticulum Export and Quality Control of Human Class I MHC Molecules1

John J. Ladasky*, Sarah Boyle*, Malini Seth2,*, Hewang Li3,*, Tsvetelina Pentcheva4,*, Fumiyoshi Abe5,*, Steven J. Steinberg{dagger} and Michael Edidin6,*

* Department of Biology, Johns Hopkins University, Baltimore, MD 21218; and {dagger} Kennedy Krieger Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205

The assembly of class I MHC molecules and their export from the endoplasmic reticulum (ER) is governed by chaperones and accessory proteins. We present evidence that the putative cargo receptor protein Bap31 participates in the transport and the quality control of human class I molecules. Transfection of the human adenocarcinoma cell line HeLa with yellow fluorescent protein-Bap31 chimeras increased surface levels of class I in a dose-dependent manner, by as much as 3.7-fold. The increase in surface class I resulted from an increase in the rate of export of newly synthesized class I molecules to the cell surface and from an increase in the stability of the exported molecules. We propose that Bap31 performs quality control on class I molecules in two distinct phases: first, by exporting peptide-loaded class I molecules to the ER/Golgi intermediate compartment, and second, by retrieving class I molecules that have lost peptides in the acidic post-ER environment. This function of Bap31 is conditional or redundant, because we find that Bap31 deficiency does not reduce surface class I levels. Overexpression of the Bap31 homolog, Bap29, decreases surface class levels in HeLa, indicating that it does not substitute for Bap31.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grant AI-14584 (to M.E.). J.J.L. was supported in part by Training Grant T32AI007247 (Mark Soloski, principal investigator).

2 Current address: Department of Medicine, Duke University Medical Center, Durham, NC 27701.

3 Current address: Department of Pediatrics, Georgetown University Medical Center, Washington, DC 20007.

4 Current address: Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

5 Current address: Japan Agency for Marine-Earth Science and Technology, Yokosuka 237-0061, Japan.

6 Address correspondence and reprint requests to Dr. Michael Edidin, Department of Biology, Johns Hopkins University, 3400 North Charles Street, Baltimore, MD 21218. E-mail address: edidin{at}jhu.edu

7 Abbreviations used in this paper: ER, endoplasmic reticulum; ERGIC, ER/Golgi intermediate compartment; CFTR, cystic fibrosis transmembrane conductance regulator; CADDS, contiguous X-linked adrenoleukodystrophy/DXS1357E deletion syndrome; X-ALD, X-linked adrenoleukodystrophy; siRNA, small interfering RNA; EGFP, enhanced GFP; YFP, yellow fluorescent protein; CFP, cyan fluorescent protein.




This article has been cited by other articles:


Home page
J. Immunol.Home page
F. Abe, N. Van Prooyen, J. J. Ladasky, and M. Edidin
Interaction of Bap31 and MHC Class I Molecules and Their Traffic Out of the Endoplasmic Reticulum
J. Immunol., April 15, 2009; 182(8): 4776 - 4783.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. A. Regan and L. A. Laimins
Bap31 Is a Novel Target of the Human Papillomavirus E5 Protein
J. Virol., October 15, 2008; 82(20): 10042 - 10051.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Y. Wakana, S. Takai, K.-i. Nakajima, K. Tani, A. Yamamoto, P. Watson, D. J. Stephens, H.-P. Hauri, and M. Tagaya
Bap31 Is an Itinerant Protein That Moves between the Peripheral Endoplasmic Reticulum (ER) and a Juxtanuclear Compartment Related to ER-associated Degradation
Mol. Biol. Cell, May 1, 2008; 19(5): 1825 - 1836.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. W. Everett and M. Edidin
Tapasin Increases Efficiency of MHC I Assembly in the Endoplasmic Reticulum but Does Not Affect MHC I Stability at the Cell Surface
J. Immunol., December 1, 2007; 179(11): 7646 - 7652.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.